#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary neuropathic amyloidosis Oesophageal atresia Ewing's sarcoma metastatic B precursor type acute leukaemia Myeloid leukaemia Duchenne muscular dystrophy Penile squamous cell carcinoma High-grade B-cell lymphoma Adenovirus infection Choroid melanoma Sarcoidosis Anal fistula Pleomorphic leiomyosarcoma Proteus syndrome Niemann-Pick disease More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Diagnostics Carcinoid syndrome – Trials in Disease Richter’s syndrome – Treatment Chondrosarcoma metastatic – Treatment Antisynthetase syndrome – Basic Information Synovial sarcoma metastatic – Diagnostics Primary immunodeficiency syndrome – Life with Disease Rhabdomyosarcoma – Diagnostics Nephrotic syndrome – Life with Disease Toxic epidermal necrolysis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Erenumab Fludarabine Phosphate D-Biotin Citric Acid Monohydrate Jk08 Evencaleucel Lt3001 Bi 706321 Amniotic Membrane, Human F510/08 Riboflavin Sodium Phosphate Darovasertib Odm-111 Emibetuzumab Doxycycline Hyclate Doxecitine Tolvaptan Fluoroestradiol F-18 Keto-Valine Calcium Tamoxifen Citrate More therapies…

    Learn about Your Condition

    CDKL5 deficiency disorder MELAS syndrome Alcohol abuse Benign prostatic hyperplasia Hepatic cancer K-ras gene mutation Spondylolisthesis Renal cancer Hip arthroplasty Langerhans' cell histiocytosis Pigmentary glaucoma Haemolytic uraemic syndrome Arrhythmia supraventricular Osteoarthritis Neuropathy peripheral More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Gornoslaskie Centrum Mwdyczne

Gornoslaskie Centrum Mwdyczne

Ul. Ziolowa 45/47, Katowice, 40-635, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Pulmonary fibrosis
    Investigated Drugs:
    • ADMILPARANT
    Austria Belgium Czechia Denmark Finland France +9

  • A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • ADMILPARANT
    Austria Belgium Czechia Denmark Finland France +9

  • Comparing certolizumab pegol and belimumab for patients with moderate or severe systemic lupus erythematosus

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Belimumab
    • Certolizumab Pegol
    Poland

  • Study on COR-1167 for Patients with Worsening Heart Failure

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure
    Czechia Hungary Poland Romania Spain

  • Study of acetylsalicylic acid and clopidogrel treatment duration after left atrial appendage closure in patients with atrial fibrillation

    Not yet recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    Poland

  • Title: Evaluation of optimal timing for heparin anticoagulation in patients undergoing transseptal heart procedures (TEER or left atrial appendage closure)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Heparin Sodium
    Poland

  • Study of acetylsalicylic acid and clopidogrel treatment after left atrial appendage closure in patients with atrial fibrillation and chronic kidney disease

    Not yet recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    Poland

  • A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Ziltivekimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Study of Levosimendan and Glucose Monohydrate for Patients with Low Ejection Fraction Takotsubo Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Stress cardiomyopathy
    Investigated Drugs:
    • Levosimendan
    • Glucose Monohydrate
    Poland

  • Study on Atorvastatin for Reducing COPD Exacerbations in Smokers with Chronic Obstructive Pulmonary Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Atorvastatin
    Poland
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!